These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

632 related articles for article (PubMed ID: 8557506)

  • 1. Dynamic contrast-enhanced magnetic resonance imaging of the breast combined with pharmacokinetic analysis of gadolinium-DTPA uptake in the diagnosis of local recurrence of early stage breast carcinoma.
    Mussurakis S; Buckley DL; Bowsley SJ; Carleton PJ; Fox JN; Turnbull LW; Horsman A
    Invest Radiol; 1995 Nov; 30(11):650-62. PubMed ID: 8557506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A pharmacokinetic analysis of Gd-DTPA enhancement in MRT in breast carcinoma].
    Hess T; Knopp MV; Hoffmann U; Brix G; Junkermann H; Zuna I; von Fournier D; van Kaick G
    Rofo; 1994 Jun; 160(6):518-23. PubMed ID: 8011997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic MR imaging of the breast combined with analysis of contrast agent kinetics in the differentiation of primary breast tumours.
    Mussurakis S; Buckley DL; Drew PJ; Fox JN; Carleton PJ; Turnbull LW; Horsman A
    Clin Radiol; 1997 Jul; 52(7):516-26. PubMed ID: 9240704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suspect breast lesions: findings at dynamic gadolinium-enhanced MR imaging correlated with mammographic and pathologic features.
    Stomper PC; Herman S; Klippenstein DL; Winston JS; Edge SB; Arredondo MA; Mazurchuk RV; Blumenson LE
    Radiology; 1995 Nov; 197(2):387-95. PubMed ID: 7480682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative signal intensity measurements in dynamic gadolinium-enhanced MR mammography.
    Gribbestad IS; Nilsen G; Fjøsne HE; Kvinnsland S; Haugen OA; Rinck PA
    J Magn Reson Imaging; 1994; 4(3):477-80. PubMed ID: 8061451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic resonance imaging in potential postsurgical recurrence of breast cancer: pitfalls and limitations.
    Cohen EK; Leonhardt CM; Shumak RS; Soutar IC; Bukhanov K; Fishell EK; Plewes DB
    Can Assoc Radiol J; 1996 Jun; 47(3):171-6. PubMed ID: 8640412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic 3D-MR mammography: is there a benefit of sophisticated evaluation of enhancement curves for clinical routine?
    Müller-Schimpfle M; Ohmenhäuser K; Sand J; Stoll P; Claussen CD
    J Magn Reson Imaging; 1997; 7(1):236-40. PubMed ID: 9039622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic analysis of Gd-DTPA enhancement in dynamic three-dimensional MRI of breast lesions.
    den Boer JA; Hoenderop RK; Smink J; Dornseiffen G; Koch PW; Mulder JH; Slump CH; Volker ED; de Vos RA
    J Magn Reson Imaging; 1997; 7(4):702-15. PubMed ID: 9243392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clustered breast microcalcifications: evaluation by dynamic contrast-enhanced subtraction MRI.
    Gilles R; Meunier M; Lucidarme O; Zafrani B; Guinebretière JM; Tardivon AA; Le Gal M; Vanel D; Neuenschwander S; Arriagada R
    J Comput Assist Tomogr; 1996; 20(1):9-14. PubMed ID: 8576489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrast-enhanced magnetic resonance imaging of the breast.
    Heywang-Köbrunner SH
    Invest Radiol; 1994 Jan; 29(1):94-104. PubMed ID: 8144345
    [No Abstract]   [Full Text] [Related]  

  • 11. Pelvic lesions in patients with treated cervical carcinoma: efficacy of pharmacokinetic analysis of dynamic MR images in distinguishing recurrent tumors from benign conditions.
    Hawighorst H; Knapstein PG; Schaeffer U; Knopp MV; Brix G; Hoffmann U; Zuna I; Essig M; van Kaick G
    AJR Am J Roentgenol; 1996 Feb; 166(2):401-8. PubMed ID: 8553955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic MRI of invasive breast cancer: assessment of three region-of-interest analysis methods.
    Mussurakis S; Buckley DL; Horsman A
    J Comput Assist Tomogr; 1997; 21(3):431-8. PubMed ID: 9135653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of preoperative MRI of the breasts on recurrence rate in patients with breast cancer.
    Fischer U; Zachariae O; Baum F; von Heyden D; Funke M; Liersch T
    Eur Radiol; 2004 Oct; 14(10):1725-31. PubMed ID: 15248080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic approach for dynamic breast MRI to indicate signal intensity time curves of benign and malignant lesions by using the tumor flow residence time.
    Renz DM; Diekmann F; Schmitzberger FF; Pietsch H; Fallenberg EM; Durmus T; Huppertz A; Böttcher J; Bick U; Hamm B; Lawaczeck R
    Invest Radiol; 2013 Feb; 48(2):69-78. PubMed ID: 23262793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic contrast-enhanced and fat suppressed magnetic resonance imaging in suspected recurrent carcinoma of the breast: preliminary experience.
    Kerslake RW; Fox JN; Carleton PJ; Imrie MJ; Cook AM; Bowsley SJ; Horsman A
    Br J Radiol; 1994 Dec; 67(804):1158-68. PubMed ID: 7874413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetic characteristics of ductal carcinoma in situ (DCIS) in dynamic breast MRI using computer-assisted analysis.
    Vag T; Baltzer PA; Dietzel M; Benndorf M; Gajda M; Camara O; Kaiser WA
    Acta Radiol; 2010 Nov; 51(9):955-61. PubMed ID: 20942728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraindividual in vivo comparison of gadolinium contrast agents for pharmacokinetic analysis using dynamic contrast enhanced magnetic resonance imaging.
    Liang J; Sammet S; Yang X; Jia G; Takayama Y; Knopp MV
    Invest Radiol; 2010 May; 45(5):233-44. PubMed ID: 20351653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic magnetic resonance mammography of both breasts following local excision and radiotherapy for breast carcinoma.
    Murray AD; Redpath TW; Needham G; Gilbert FJ; Brookes JA; Eremin O
    Br J Radiol; 1996 Jul; 69(823):594-600. PubMed ID: 8696694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MR imaging of the breast after surgery for breast cancer.
    Whitehouse GH; Moore NR
    Magn Reson Imaging Clin N Am; 1994 Nov; 2(4):591-603. PubMed ID: 7489311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Gadolinium-DTPA (Magnevist) as contrast medium for galactography].
    Kaltenborn H; Schadmand S; Beck T; Thelen M
    Rofo; 1995 Nov; 163(5):457-9. PubMed ID: 8527765
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 32.